The Roles of Tissue Factor in Malignant Gliomas
| Status: | Completed |
|---|---|
| Conditions: | Brain Cancer, Brain Cancer, Cardiology, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/7/2017 |
| Start Date: | January 2004 |
| End Date: | October 2006 |
To explore the relationship between tissue factor levels, tumour progression, activation of
blood coagulation and venous thromboembolism with malignant glioma
blood coagulation and venous thromboembolism with malignant glioma
To explore the relationship between tissue factor levels, tumour progression, activation of
blood coagulation and venous thromboembolism with malignant glioma
blood coagulation and venous thromboembolism with malignant glioma
Inclusion Criteria:
- participation in PRODIGE
- adult patients
- newly diagnosed, biopsy-confirmed grade III/IV malignant gliomas
- undergone craniotomy or stereotactic biopsy > 2 days and < 4 weeks before
Exclusion Criteria:
- have known hereditary thrombophilia
- are receiving experimental antiangiogenic therapy
We found this trial at
3
sites
Henry Ford Hospital Founded in 1915 by auto pioneer Henry Ford and now one of...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials